MedTrace Logo

Evaluation of a 28-day Fermented Milk Product Consumption Twice Daily as Compared to a Non-fermented Milk Product on Intestinal Gas Production in Healthy Subjects High Dihydrogen Producers

NCT03015441 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2017-08-22

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of a 28-day fermented milk product consumption twice daily on intestinal gas production of dihydrogen (H2) and methane (CH4) in healthy subjects high H2 producers.

Conditions

  • Excessive Intestinal Gas Production

Interventions

OTHER

Milk product fermented by lactic bacteria or not fermented

2 pots of 125g consumed daily during 28 days

Sponsors & Collaborators

  • Danone Global Research & Innovation Center

    lead INDUSTRY

Principal Investigators

  • Boris Le NEVE, PhD · Danone Research, Palaiseau, France

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-02
Primary Completion
2017-05-04
Completion
2017-06-21

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03015441 on ClinicalTrials.gov